Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

CUSIP: 22978P106

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 7 signals
Share change
-373,442
Put/Call ratio
48%
SEC-reported price per share
$11.31
Number of holders
88
Value change
-$11,058,319
Number of buys
46
Open additional details 1 more signal available
Number of sells
37
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
43,411,663

Security key

22978P106

Report period

Q4 2021

Institutions

88

Top holders

10

Ownership snapshot

Top reported holders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
Nantahala Capital Managem...
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F Highest disclosed value: $37,461,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Nantahala Capital Management, LLC has the largest disclosed position value at $37.46M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Nantahala Capital Management, LLC's linked filing trail.
Disclosed position value Top 5
Nantahala Capital Management, LLC $37.46M
BlackRock Finance, Inc. $31.48M
VANGUARD GROUP INC $22.93M
Slate Path Capital LP $21.62M
STATE STREET CORP $19.04M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$37,461,000
2,571,082 shares
— 30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$31,476,000
2,160,458 shares
— 30 Sep 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$22,930,000
1,573,720 shares
— 30 Sep 2021
Slate Path Capital LP
13F
Company
13F
—
denominator unverified
$21,616,000
1,483,619 shares
— 30 Sep 2021
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$19,035,000
1,306,446 shares
— 30 Sep 2021
Corriente Advisors, LLC
13F
Company
13F
—
denominator unverified
$13,818,000
948,389 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
88
Shares
16,533,577
Rows available
88
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q4 2025 Across Filers

Q4 2025 holders
48
Q4 2021 holders
88
Holder diff
40
Investor Q4 2025 Shares Q4 2021 Shares Share Diff Share Chg % Q4 2025 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .